Oxysterols in adipose tissue-derived mesenchymal stem cell proliferation and death
Cell death
Adult
Cell Survival
Adipose tissue
Apoptosis
Mitochondrial hyperpolarization
Membrane Potentials
Necrosis
03 medical and health sciences
Oxysterol
Autophagy
Humans
Fluorescent Antibody Technique, Indirect
Ketocholesterols
Mesenchymal stem cell
Cell Proliferation
Caspase 7
0303 health sciences
Cholestanes
Caspase 3
Cell Cycle
Mesenchymal Stem Cells
Middle Aged
Actins
Mitochondria
3. Good health
Adipose Tissue
Female
DOI:
10.1016/j.jsbmb.2016.04.017
Publication Date:
2016-04-30T17:38:59Z
AUTHORS (8)
ABSTRACT
Mesenchymal stem cells (MSCs) are multipotent cells characterized by self-renewal and cellular differentiation capabilities. Oxysterols comprise a very heterogeneous group derived from cholesterol through enzymatic and non-enzymatic oxidation. Potent effects in cell death processes, including cytoxicity and apoptosis induction, were described in several cell lines. Very little is known about the effects of oxysterols in MSCs. 7-ketocholesterol (7-KC), one of the most important oxysterols, was shown to be cytotoxic to human adipose tissue-derived MSCs. Here, we describe the short-term (24h) cytotoxic effects of cholestan-3α-5β-6α-triol, 3,5 cholestan-7-one, (3α-5β-6α)- cholestane-3,6-diol, 7-oxocholest-5-en-3β-yl acetate, and 5β-6β epoxy-cholesterol, on MSCs derived from human adipose tissue. MSCs were isolated from adipose tissue obtained from three young, healthy women. Oxysterols, with the exception of 3,5 cholestan-7-one and 7-oxocholest-5-en-3β-yl acetate, led to a complex mode of cell death that include apoptosis, necrosis and autophagy, depending on the type of oxysterol and concentration, being cholestan-3α-5β-6α-triol the most effective. Inhibition of proliferation was also promoted by these oxysterols, but no changes in cell cycle were observed.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (45)
CITATIONS (12)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....